Healthcare News and Research

Latest Healthcare News and Research

Isis Pharmaceuticals begins ISIS-FXI Rx Phase 2 study in patients with ESRD on hemodialysis

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.

30 Oct 2015

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

30 Oct 2015

FairCare named Top 3 most promising companies at 4th Annual HealthTech Conference

FairCare, a medical big data startup based in Silicon Valley that has uncovered millions of medical prices nationwide, was named in the Top 3 most promising companies at the 4th Annual HealthTech Conference on October 27-28, 2015.

30 Oct 2015

Study suggests a neural pathway through which early life stress may contribute to depression

Early life stress is a major risk factor for later episodes of depression. In fact, adults who are abused or neglected as children are almost twice as likely to experience depression.

30 Oct 2015

Study finds no major difference in hippocampal size between men and women

A research study at Rosalind Franklin University of Medicine and Science has debunked the widely-held belief that the hippocampus, a crucial part of the brain that consolidates new memories and helps connect emotions to the senses, is larger in females than in males.

30 Oct 2015

2015 Carousel Ball raises over $1.2M to support Buerger Center for Advanced Pediatric Care

The Children's Hospital of Philadelphia's (CHOP) 2015 Carousel Ball raised more than $1.2 million to support The Buerger Center for Advanced Pediatric Care.

30 Oct 2015

New magnetic field delivery method could help treat traumatic brain injury

Treating traumatic brain injury (TBI) using stem cell therapy is an important area of current research. However, injecting stem cells into the central nervous system has serious drawbacks, including intracranial hemorrhage and cells failing to reach TBI-affected areas of the brain.

30 Oct 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.

From Omnicell, Inc. 30 Oct 2015

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

Protein Sciences Corporation, the makers of Flublok Influenza Vaccine, announced today that Dr. Manon Cox, President and CEO, was elected as a 2015 Fellow of the International Society for Vaccines (ISV). The ISV is an esteemed organization dedicated to the development, advancement and use of vaccines to prevent and control disease.

30 Oct 2015

Omnicell signs definitive agreement to acquire Aesynt

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced it has entered into a definitive agreement to acquire Aesynt Incorporated.

From Omnicell, Inc. 30 Oct 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Gastric cancer, otherwise known as stomach cancer, does not respond well to existing treatments and it is currently the third leading cause of cancer death in the world (after lung and liver cancer). Researchers have discovered that certain drugs, currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat certain gastric cancers with a particular pattern of mutations (genomic molecular fingerprint).

29 Oct 2015

Scientists call for coordinated effort to drive cutting edge microbiome research

A consortium of 48 scientists from 50 institutions in the United States - including Pamela Silver, Ph.D., a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University - are calling for a Unified Microbiome Initiative that would span national cross-institutional and cross-governmental agency support.

29 Oct 2015

Many nonprofit hospitals have room to improve charity care and emergency care policies

If you don't have health insurance, or your insurance coverage still leaves you with big bills, hospitals are supposed to let you know if you qualify for free or reduced-price care, and to charge you fairly even if you don't.

29 Oct 2015

New research reveals regional variations in use of heroin and prescription painkillers

New research shows that drug abusers are not completely abandoning prescription opioids for heroin. Instead, many use the two concurrently based on their availability, according to a survey of 15,000 patients at drug-treatment centers in 49 states.

29 Oct 2015

Researchers working to improve health and physical performance of soldiers

Researchers from around the world are working to improve soldiers' health and physical performance and health--with the goal of increasing military readiness and effectiveness, according to the November special issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

29 Oct 2015

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

A large international study shows that breastfeeding is associated with a lower risk of developing an aggressive form of breast cancer called hormone-receptor negative. This new combined evidence shows the risk was reduced by up to 20% in women who breastfed.

29 Oct 2015

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

A radiotherapeutic bandage is being evaluated by researchers for efficacy against squamous cell carcinoma (SCC) in an animal model. These results could confirm the viability of a new and improved strategy for the radiotherapeutic treatment of skin cancer in the clinic. This work is being presented Oct. 28 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.

29 Oct 2015

Mount Sinai researchers provide a glimpse of precision medicine in action

A new publication from scientists at the Icahn School of Medicine at Mount Sinai offers a glimpse of precision medicine in action, with a massive data analysis project that identified clinically and genetically distinct subtypes of patients with type 2 diabetes. This work not only points to the possibility for more tailored diagnosis and treatment of type 2 diabetes in the future, but also reveals a novel approach that can be applied to virtually any disease.

29 Oct 2015

Race differentiates beliefs in physician trust, study finds

A new Emory University study could help provide a clearer understanding of why black and Latino patients are less likely to trust their physicians than white patients.

29 Oct 2015

Healthcare News and Research

Latest Healthcare News and Research

Isis Pharmaceuticals begins ISIS-FXI Rx Phase 2 study in patients with ESRD on hemodialysis

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

FairCare named Top 3 most promising companies at 4th Annual HealthTech Conference

Study suggests a neural pathway through which early life stress may contribute to depression

Study finds no major difference in hippocampal size between men and women

2015 Carousel Ball raises over $1.2M to support Buerger Center for Advanced Pediatric Care

New magnetic field delivery method could help treat traumatic brain injury

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

Omnicell signs definitive agreement to acquire Aesynt

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Scientists call for coordinated effort to drive cutting edge microbiome research

Many nonprofit hospitals have room to improve charity care and emergency care policies

New research reveals regional variations in use of heroin and prescription painkillers

Researchers working to improve health and physical performance of soldiers

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

Mount Sinai researchers provide a glimpse of precision medicine in action

Race differentiates beliefs in physician trust, study finds

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in